| Wockhardt Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532300 |
NSE Symbol : WOCKPHARMA |
P/E(TTM) : 95.73 |
|
ISIN Demat : INE049B01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 17.97 |
|
Book Value(₹) : 189.81 |
Market Cap(₹Cr) : 27,952.72 |
Face Value(₹) : 5.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 516.00 | 430.00 | 380.00 | 413.00 | 355.00 | 325.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 516.00 | 430.00 | 380.00 | 413.00 | 355.00 | 325.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 90.00 | 27.00 | 30.00 | 25.00 | 14.00 | 6.00 |
| Total Income | 606.00 | 457.00 | 410.00 | 438.00 | 369.00 | 331.00 |
| Total Expenditure | 355.00 | 327.00 | 267.00 | 282.00 | 249.00 | 263.00 |
| PBIDT | 251.00 | 130.00 | 143.00 | 156.00 | 120.00 | 68.00 |
| Interest | 41.00 | 50.00 | 44.00 | 41.00 | 40.00 | 48.00 |
| PBDT | 210.00 | 80.00 | 99.00 | 115.00 | 80.00 | 20.00 |
| Depreciation | 43.00 | 52.00 | 45.00 | 46.00 | 40.00 | 42.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 167.00 | 28.00 | 54.00 | 69.00 | 40.00 | -22.00 |
| Extra-ordinary Items | 35.00 | -10.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 132.00 | 38.00 | 54.00 | 69.00 | 40.00 | -22.00 |
| EPS (Unit Curr.) | 10.29 | 1.73 | 3.26 | 4.25 | 2.47 | -1.40 |
| EPS (Adj) (Unit Curr.) | 10.29 | 1.73 | 3.26 | 4.25 | 2.47 | -1.40 |
| Calculated EPS (Unit Curr.) | 10.31 | 1.73 | 3.33 | 4.26 | 2.47 | -1.36 |
| Calculated EPS (Adj) (Unit Curr.) | 10.31 | 1.73 | 3.33 | 4.26 | 2.47 | -1.36 |
| Calculated EPS (Ann.) (Unit Curr.) | 41.23 | 6.91 | 13.33 | 17.04 | 9.88 | -5.43 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 41.23 | 6.91 | 13.33 | 17.04 | 9.88 | -5.43 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 81.00 | 81.00 | 81.00 | 81.00 | 81.00 | 81.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 48.64 | 30.23 | 37.63 | 37.77 | 33.80 | 20.92 |
| PBDTM(%) | 40.70 | 18.60 | 26.05 | 27.85 | 22.54 | 6.15 |
| PATM(%) | 32.36 | 6.51 | 14.21 | 16.71 | 11.27 | -6.77 |
